Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress
September 25, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human...
Steakholder Foods® Signs Commercial Sales Agreement for its Plant-Based Premixes with Bondor Foods
September 25, 2024 07:00 ET
|
STEAKHOLDER FOODS LTD.
Agreement Enables Bondor Foods to Launch Production of White Fish Kebab and Salmon Patties Developed Using Steakholder Foods’ Premixes, Marking Transition to Large-Scale Manufacturing Rehovot,...
OncoC4 and AcroImmune Announce Merger
September 25, 2024 07:00 ET
|
OncoC4, Inc.
Merger expands OncoC4’s wholly owned immunotherapy pipeline and establishes in-house clinical manufacturing capabilities Adds IND-ready AI-081, a PD-1/VEGF bispecific antibody with best-in-class...
Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors
September 25, 2024 07:00 ET
|
Atavistik Bio, Inc.
Atavistik Bio announced today the appointment of oncology clinical development leader Mohammad Hirmand, M.D. to its Board of Directors.
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
September 25, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on...
Climb Channel Solutions Announces A-LIGN, Security and Compliance Partner, as Global Contract
September 25, 2024 07:00 ET
|
Climb Channel Solutions
EATONTOWN, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:...
Presenting on the Emerging Growth Conference 75 Day 2 on September 26
September 25, 2024 07:00 ET
|
Emerging Growth
MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26,...
Stingray Renews its Normal Course Issuer Bid
September 25, 2024 07:00 ET
|
Stingray Group Inc.
MONTREAL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Stingray Group Inc. (TSX: RAY.A; RAY.B) (“Stingray”), an industry leader in music and video content distribution, business services, and advertising...
Microbix Presenting at Muskoka Capital Conference
September 25, 2024 07:00 ET
|
Microbix Biosystems Inc.
Microbix Biosystems Inc. will be presenting to investors at the Muskoka Capital Conference.
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024 07:00 ET
|
Genespire
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the largest private Italian Biotech company financings...
- September 25, 2024 06:55 ET Taiwan Alternative Lending Business Databook 2024: A $480+ Million Market by 2028 - 75+ KPIs on Alternative Lending Market Size, End User, Finance Model, Payment Instrument, Loan Type and Demographics
- September 25, 2024 06:00 ET Chuck E. Cheese BOO-Tacular Returns for Family & Spooky-Fun as the Largest Kids-Focused National Halloween Event